Merck & Co.’s Keytruda Gets Fighting Chance In TNBC

Successful KEYNOTE-522 Results May Sway FDA

 
• By Alaric DeArment
  
Cancer
Merck & Co. announced positive results for Keytruda in TNBC • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Immuno-oncology

More from Anticancer